Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19

• Markus Blaess,
• Lars Kaiser,
• Lars Kaiser,
• Oliver Sommerfeld,
• Simone Rentschler,
• René Csuk,
• Hans-Peter Deigner,
• Hans-Peter Deigner,
• Hans-Peter Deigner

Affiliations

Markus Blaess

Institute of Precision Medicine, Medical and Life Sciences Faculty, Furtwangen University, Villingen-Schwenningen, Germany

Lars Kaiser

Institute of Precision Medicine, Medical and Life Sciences Faculty, Furtwangen University, Villingen-Schwenningen, Germany

Lars Kaiser

Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany

Oliver Sommerfeld

Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany

Simone Rentschler

Institute of Precision Medicine, Medical and Life Sciences Faculty, Furtwangen University, Villingen-Schwenningen, Germany

René Csuk

Department of Organic Chemistry, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Hans-Peter Deigner

Institute of Precision Medicine, Medical and Life Sciences Faculty, Furtwangen University, Villingen-Schwenningen, Germany

Hans-Peter Deigner

EXIM Department, Fraunhofer Institute IZI Leipzig, Rostock, Germany

Hans-Peter Deigner

Faculty of Science, Tuebingen University, Tübingen, Germany